CoChat

Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer

Open access
Malik, Arshi, Afaq, Farrukh, Sarfaraz, Sami, Adhami, Vaqar M., Syed, Deeba N., Mukhtar, Hasan · 2005 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Prostate cancer is the most common invasive malignancy and the second leading cause of cancer-related deaths among U.S. males, with a similar trend in many Western countries. One approach to control this malignancy is its prevention through the use of agents present in diet consumed by humans. Pomegranate from the tree Punica granatum possesses strong antioxidant and antiinflammatory properties. We recently showed that pomegranate fruit extract (PFE) possesses remarkable antitumor-promoting effects in mouse skin. In this study, employing human prostate cancer cells, we evaluated the antiproliferative and proapoptotic properties of PFE. PFE (10-100 μg/ml; 48 h) treatment of highly aggressive human prostate cancer PC3 cells resulted in a dose-dependent inhibition of cell growth/cell viability and induction of apoptosis. Immunoblot analysis revealed that PFE treatment of PC3 cells resulted in ( i ) induction of Bax and Bak (proapoptotic); ( ii ) down-regulation of Bcl-X L and Bcl-2 (antiapoptotic); ( iii ) induction of WAF1/p21 and KIP1/p27; ( iv ) a decrease in cyclins D1, D2, and E; and ( v ) a decrease in cyclin-dependent kinase (cdk) 2, cdk4, and cdk6 expression. These data establish the involvement of the cyclin kinase inhibitor-cyclin-cdk network during the antiproliferative effects of PFE. Oral administration of PFE (0.1% and 0.2%, wt/vol) to athymic nude mice implanted with androgen-sensitive CWR22Rν1 cells resulted in a significant inhibition in tumor growth concomitant with a significant decrease in serum prostate-specific antigen levels. We suggest that pomegranate juice may have cancer-chemopreventive as well as cancer-chemotherapeutic effects against prostate cancer in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0505870102

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 5

  1. Parnes, H. L., House, M. G., Kagan, J., Kausal, D. J. & Lieberman, R. (2004) J. Urol. 171, S68-S74.14713758
  2. Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M. & Kedar, A. A. (2000) J. Agric. Food Chem. 10, 4581-4589.
  3. Caporali, A., Davalli, P., Astancolle, S., D'Arca, D., Brausi, M., Bettuzzi, S. & Corti, A. (2004) Carcinogenesis 11, 2217-2224.
  4. Naz, R. K. & Herness, E. A. (2001) Front. Biosci. 6, 1083-1088.
  5. McDonald, E. R. & El Deiry, W. S. (2000) Int. J. Oncol. 16, 871-886.10762622

Cited by

See all 404

Metadata

Authors
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H.
Affiliations
University of Wisconsin–Madison (US)
Venue
Proceedings of the National Academy of Sciences
Published
2005-09-28
Volume
102
Issue
41
Pages
14813-14818
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2084780129
Cited by
401
References
45
Citations by year
2026: 1 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 19 · 2020: 16 · 2019: 18 · 2018: 17 · 2017: 18 · 2016: 28 · 2015: 21 · 2014: 31 · 2013: 29 · 2012: 29
FWCI
18.62
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA101039, R01CA078809)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Natural Compound Pharmacology Studies
Keywords
pomegranate fruit extract, Punica granatum, prostate cancer, chemoprevention, chemotherapy, apoptosis, antiproliferative activity, Bcl-2 family proteins, cyclin-dependent kinases, cyclin D1, PC-3 cells, prostate-specific antigen, dietary antioxidants
MeSH terms
Animals, Cell Survival, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Humans, Male, Phytotherapy, Mice, Nude, Microscopy, Fluorescence, Plant Extracts, Prostatic Neoplasms, Time Factors, Immunoblotting, Gene Expression Regulation, Neoplastic, Apoptosis, Lythraceae, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. https://app.cochat.ai/papers/10.1073/pnas.0505870102
The paper
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H. (2005). Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0505870102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.